NIHR Maudsley BRC Blog

Our latest news & events

NIHR Maudsley BRC receives new investment from Government

The National Institute for Health and Care Research (NIHR) has awarded £41 million to the NIHR Maudsley Biomedical Research Centre (BRC) at South London and Maudsley NHS Foundation Trust and the Institute of Psychiatry, Psychology & Neuroscience at King’s College London. The NIHR funding is for five years from 1 December 2022 to 30 November 2027.

By NIHR Maudsley BRC at 14 Oct 2022

‘Drug related deaths are avoidable’ - South London and Maudsley and King's College London mark International Overdose Awareness Day 2022

Maudsley Hospital, King’s College London’s National Addiction Centre, Institute of Psychiatry, Psychology & Neuroscience main building, and The Weston Education Centre will light up purple to raise awareness for International Overdose Awareness Day 2022 and share the message that drug related deaths are avoidable.

 

By NIHR Maudsley BRC at 31 Aug 2022

In search of lost treatment: how mental health research can be part of patient care plans

Dr Maria Antonietta (Etta) Nettis is a Consultant Psychiatrist at the National Psychosis Unit at King’s College London and a researcher within the Research and Development (R&D) team at South London and Maudsley NHS Foundation Trust. Etta writes about why research at the Trust is so important for improving patient care and her team’s facilitating role.

By NIHR Maudsley BRC at 30 Aug 2022

Bringing experience and research together to understand psychosis

Recently a group of researchers, clinicians and people with lived experience worked on a project to depict psychosis in a way that better represented the range of experience. The result was a research paper in the journal World Psychiatry. In this blog the authors talk about this novel approach and the value it brings. It includes direct quotes from some of the authors about the project.

By NIHR Maudsley BRC at 29 Jul 2022

NIHR Maudsley BRC researchers lead first study of psilocybin in adults with autism

Researchers from King’s College London and South London and Maudsley NHS Foundation Trust will be leading the first ever study of psilocybin in adults with autism spectrum disorder (ASD). 

By NIHR Maudsley BRC at 9 May 2022